VarCT Diagnostics ApS: Financial statements 2020
CVR: 38733567
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
VarCT Diagnostics ApS (CVR 38733567) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,174,678 and a net result of DKK -760,968 compared with DKK -3,221,331 the year before. Equity in the 2020 report amounted to DKK 8,742,104. The solvency ratio was 85.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,174,678
- Profit/Loss
- DKK -760,968
- Equity
- DKK 8,742,104
- Total Assets
- DKK 10,266,444
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.2 mio. | -761 t. | 8.7 mio. | 3 |
| 2019 | - | -2 mio. | -3.2 mio. | 9.5 mio. | 3 |
| 2018 | - | -472 t. | -1.8 mio. | 12.7 mio. | 2 |
Official annual report
How creditworthy is VarCT Diagnostics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
VarCT Diagnostics ApS has published its annual report for 2019. Gross profit came to DKK -2,020,592, and the net result was DKK -3,221,331.
As of March 31, 2020, Ulf Andreas Linderoth Norlin has stepped down as director of VarCT Diagnostics ApS.
About VarCT Diagnostics ApS
VarCT Diagnostics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The board consists of Mads Daugaard (chair), Ali El-Salanti, Josef Rainer and Peter Schröcksnadel. The company is owned by VAR2 PHARMACEUTICALS ApS and Sitour Management m.b.H.. The company has 4 employees (2018). In 2025, the company reported a gross profit of DKK 176,862 and a net result of DKK -1,961,493 compared with DKK 779,245 the year before. Equity in the 2025 report amounted to DKK 2,238,264.